Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Age-Adjusted D-Dimer Cut-Off Levels to Rule-out Venous Thromboembolism in Patients with Non-High Pre-Test Probability. Clinical Performance and Cost-Effectiveness Analysis

Pierre A. Toulon, MD PhD, Neila De Pooter, MD, Marie Brionne-François, MD, Motalib Smahi, MD, Lien Abecassis, MD

Blood (2016) 128 (22): 4729.

https://doi.org/10.1182/blood.V128.22.4729.4729

Published: 2016

Journal Articles

Age Dependency Of Coagulation Parameters During Childhood

Pierre A. Toulon, MD, PhD, Julien Arcizet, MD, François Grand, MD, Neila De Pooter, MD, Dominique Lasnes, MD, PhD, Marie Brionne-François, MD

Blood (2013) 122 (21): 2341.

https://doi.org/10.1182/blood.V122.21.2341.2341

Published: 2013

Journal Articles

Performance of Age-Adjusted D-Dimer Cut-off Values to Rule Out Venous Thromboembolism in Patients with Non-High Pre-Test Probability

Pierre A. Toulon, MD, PhD, Yann-Erick Claessens, MD, PhD

Blood (2012) 120 (21): 1147.

https://doi.org/10.1182/blood.V120.21.1147.1147

Published: 2012

Journal Articles

Economic Impact of a Screening Strategy for Protein C Pathway Abnormalities Based on a New Global Chromogenic Assay (HemosIL ThromboPath) as a First Step Screening Assay In a Series of 597 Unselected Consecutive Patients.

Pierre A. Toulon, MD, PhD, Isabelle Martin-Toutain, MD, Annick Ankri, MD

Blood (2010) 116 (21): 3822.

https://doi.org/10.1182/blood.V116.21.3822.3822

Published: 2010

Journal Articles

Monitoring Treatments with Unfractionated Heparin: CTAD Must Be Used Instead of Citrate as the Anticoagulant Solution When Using Partial-Draw Collection Tubes.

Pierre A. Toulon, MD, PhD, Lién Abecassis, MD, Motalib Smahi, MD, Catherine Ternisien, MD

Blood (2009) 114 (22): 2091.

https://doi.org/10.1182/blood.V114.22.2091.2091

Published: 2009

NARROW

Age-Adjusted D-Dimer Cut-Off Levels to Rule-out Venous Thromboembolism in Patients with Non-High Pre-Test Probability. Clinical Performance and Cost-Effectiveness Analysis

Age Dependency Of Coagulation Parameters During Childhood

Performance of Age-Adjusted D-Dimer Cut-off Values to Rule Out Venous Thromboembolism in Patients with Non-High Pre-Test Probability

Economic Impact of a Screening Strategy for Protein C Pathway Abnormalities Based on a New Global Chromogenic Assay (HemosIL ThromboPath) as a First Step Screening Assay In a Series of 597 Unselected Consecutive Patients.

Monitoring Treatments with Unfractionated Heparin: CTAD Must Be Used Instead of Citrate as the Anticoagulant Solution When Using Partial-Draw Collection Tubes.

Email alerts

ASH Publications

American Society of Hematology

Age-Adjusted D-Dimer Cut-Off Levels to Rule-out Venous Thromboembolism in Patients with Non-High Pre-Test Probability. Clinical Performance and Cost-Effectiveness Analysis

Age Dependency Of Coagulation Parameters During Childhood

Performance of Age-Adjusted D-Dimer Cut-off Values to Rule Out Venous Thromboembolism in Patients with Non-High Pre-Test Probability

Economic Impact of a Screening Strategy for Protein C Pathway Abnormalities Based on a New Global Chromogenic Assay (HemosIL ThromboPath) as a First Step Screening Assay In a Series of 597 Unselected Consecutive Patients.

Monitoring Treatments with Unfractionated Heparin: CTAD Must Be Used Instead of Citrate as the Anticoagulant Solution When Using Partial-Draw Collection Tubes.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only